Claus Rödel


Ontology type: schema:Person     


Person Info

NAME

Claus

SURNAME

Rödel

Publications in SciGraph latest 50 shown

  • 2018-12 CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2018-11 Cost analysis of a wait-and-see strategy after radiochemotherapy in distal rectal cancer in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2018-09 Treatment planning for spinal radiosurgery in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2018-08 Nivolumab für das vorbehandelte metastasierte Analkarzinom in GASTRO-NEWS
  • 2018-08 Patterns of care analysis for head & neck cancer of unknown primary site: a survey inside the German society of radiation oncology (DEGRO) in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2018-06 Radiochemotherapie beim Harnblasenkarzinom in DER UROLOGE
  • 2018-05 Nivolumab für das vorbehandelte metastasierte Analkarzinom in INFO ONKOLOGIE
  • 2018-04 Nivolumab für das vorbehandelte metastasierte Analkarzinom in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2018-02 Breathing-motion-compensated robotic guided stereotactic body radiation therapy in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2018-01 (Invasives) Harnblasenkarzinom – ein interdisziplinärer Ausblick in DER ONKOLOGE
  • 2018-01 Radiochemotherapie des Harnblasenkarzinoms in DER ONKOLOGE
  • 2018 When Should Preoperative Radiochemotherapy Be Performed? in MULTIDISCIPLINARY MANAGEMENT OF RECTAL CANCER
  • 2018 Radiation Therapy in Bladder Cancer in RADIATION ONCOLOGY
  • 2018 Radiation Therapy in Rectal Cancer in RADIATION ONCOLOGY
  • 2017-12 A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling in SCIENTIFIC REPORTS
  • 2017-12 Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site – current status and challenges in RADIATION ONCOLOGY
  • 2017-12 Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial in RADIATION ONCOLOGY
  • 2017-09 Optimales Fraktionierungsschema und Zeitintervall zwischen Radiotherapie und Operation beim Rektumkarzinom in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2017-09 Welche Bedeutung hat die Inklusion von Oxaliplatin? in INFO ONKOLOGIE
  • 2017-09 A clinical example of extreme dose exposure for an implanted cardioverter–defibrillator in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2017-09 High-dose-rate brachytherapy as salvage modality for locally recurrent prostate cancer after definitive radiotherapy in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2017-08 Erratum to: Combined p16 and p53 expression in cervical cancer of unknown primary and other prognostic parameters in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2017-07 Wie lange sollte bis zur Beurteilung des Therapieansprechens nach Radiochemotherapie des Analkarzinoms gewartet werden? in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2017-04 Combined p16 and p53 expression in cervical cancer of unknown primary and other prognostic parameters in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2017-02 Inklusion von Oxaliplatin in die multimodale Behandlung des lokal fortgeschrittenen Rektumkarzinoms in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2016-12 Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases in RADIATION ONCOLOGY
  • 2016-09 Micropapillary morphology is an indicator of poor prognosis in patients with urothelial carcinoma treated with transurethral resection and radiochemotherapy in VIRCHOWS ARCHIV
  • 2016-08 Ligand stimulation of CD95 induces activation of Plk3 followed by phosphorylation of caspase-8 in CELL RESEARCH
  • 2016-07 Lymphknotenmetastasen beim ypT1/2-Rektumkarzinom nach neoadjuvanter Radiochemotherapie in DER CHIRURG
  • 2016-01 Hedgehog pathway inhibitor in combination with radiation therapy for basal cell carcinomas of the head and neck in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2015-12 The SMAC mimetic BV6 sensitizes colorectal cancer cells to ionizing radiation by interfering with DNA repair processes and enhancing apoptosis in RADIATION ONCOLOGY
  • 2015-09 Erratum to: Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2015-09 Study of the anti-inflammatory effects of low-dose radiation in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2015-08 Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2015-02 Behandlungsalgorithmus zum Rektumkarzinom in DER ONKOLOGE
  • 2015-02 Rektumkarzinom – Interdisziplinarität im Mittelpunkt in DER ONKOLOGE
  • 2015-02 Effect of dose reduction on image registration and image quality for cone-beam CT in radiotherapy in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2014-12 A non-linear detection of phospho-histone H2AX in EA.hy926 endothelial cells following low-dose X-irradiation is modulated by reactive oxygen species in RADIATION ONCOLOGY
  • 2014-10 Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences in BRITISH JOURNAL OF CANCER
  • 2014-10 New possibilities for volumetric-modulated arc therapy using the AgilityTM 160-leaf multileaf collimator in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2014-03 Concomitant chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy as definitive, first line treatment of squamous cell carcinoma of the head and neck in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2014-02 Unusual acute and delayed skin reactions during and after whole-brain radiotherapy in combination with the BRAF inhibitor vemurafenib in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2014-02 To combine or not combine: the role of radiotherapy and targeted agents in the treatment for renal cell carcinoma in WORLD JOURNAL OF UROLOGY
  • 2014-01 Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer in BRITISH JOURNAL OF CANCER
  • 2014-01 Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer in BRITISH JOURNAL OF CANCER
  • 2013-12 Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer in RADIATION ONCOLOGY
  • 2013-12 Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction in BMC CANCER
  • 2013-10 Female sex is an independent risk factor for reduced overall survival in bladder cancer patients treated by transurethral resection and radio- or radiochemotherapy in WORLD JOURNAL OF UROLOGY
  • 2013-08 Reply to the letter of Junginger et al. Strahlenther Onkol 2013 DOI 10.1007/s00066-013-0353-y in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2013-06 Perioperative Therapie des lokal fortgeschrittenen Rektumkarzinoms in COLOPROCTOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.7497.d", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412468.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418165.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411984.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.10493.3f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411088.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.8379.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.419838.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7839.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4488.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4562.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.9647.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5330.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7450.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7727.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.16149.3b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411339.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.9018.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418872.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.414836.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411668.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.6363.0", 
            "type": "Organization"
          }
        ], 
        "familyName": "R\u00f6del", 
        "givenName": "Claus", 
        "id": "sg:person.01110566562.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110566562.10"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T15:01", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_720.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01110566562.10'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01110566562.10'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01110566562.10'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01110566562.10'


     

    This table displays all metadata directly associated to this object as RDF triples.

    58 TRIPLES      10 PREDICATES      32 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01110566562.10 schema:affiliation N5d90c456504a4b4ba44d06d355bd0d31
    2 https://www.grid.ac/institutes/grid.10493.3f
    3 https://www.grid.ac/institutes/grid.16149.3b
    4 https://www.grid.ac/institutes/grid.411088.4
    5 https://www.grid.ac/institutes/grid.411339.d
    6 https://www.grid.ac/institutes/grid.411668.c
    7 https://www.grid.ac/institutes/grid.411984.1
    8 https://www.grid.ac/institutes/grid.412468.d
    9 https://www.grid.ac/institutes/grid.414836.c
    10 https://www.grid.ac/institutes/grid.418165.f
    11 https://www.grid.ac/institutes/grid.418872.0
    12 https://www.grid.ac/institutes/grid.419838.f
    13 https://www.grid.ac/institutes/grid.4488.0
    14 https://www.grid.ac/institutes/grid.4562.5
    15 https://www.grid.ac/institutes/grid.5330.5
    16 https://www.grid.ac/institutes/grid.6363.0
    17 https://www.grid.ac/institutes/grid.7450.6
    18 https://www.grid.ac/institutes/grid.7727.5
    19 https://www.grid.ac/institutes/grid.7839.5
    20 https://www.grid.ac/institutes/grid.8379.5
    21 https://www.grid.ac/institutes/grid.9018.0
    22 https://www.grid.ac/institutes/grid.9647.c
    23 schema:familyName Rödel
    24 schema:givenName Claus
    25 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110566562.10
    26 schema:sdDatePublished 2019-03-07T15:01
    27 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    28 schema:sdPublisher Nc2145cce3c554c67b84fedf97c2fd115
    29 sgo:license sg:explorer/license/
    30 sgo:sdDataset persons
    31 rdf:type schema:Person
    32 N5d90c456504a4b4ba44d06d355bd0d31 schema:affiliation https://www.grid.ac/institutes/grid.7497.d
    33 sgo:isCurrent true
    34 rdf:type schema:OrganizationRole
    35 Nc2145cce3c554c67b84fedf97c2fd115 schema:name Springer Nature - SN SciGraph project
    36 rdf:type schema:Organization
    37 https://www.grid.ac/institutes/grid.10493.3f schema:Organization
    38 https://www.grid.ac/institutes/grid.16149.3b schema:Organization
    39 https://www.grid.ac/institutes/grid.411088.4 schema:Organization
    40 https://www.grid.ac/institutes/grid.411339.d schema:Organization
    41 https://www.grid.ac/institutes/grid.411668.c schema:Organization
    42 https://www.grid.ac/institutes/grid.411984.1 schema:Organization
    43 https://www.grid.ac/institutes/grid.412468.d schema:Organization
    44 https://www.grid.ac/institutes/grid.414836.c schema:Organization
    45 https://www.grid.ac/institutes/grid.418165.f schema:Organization
    46 https://www.grid.ac/institutes/grid.418872.0 schema:Organization
    47 https://www.grid.ac/institutes/grid.419838.f schema:Organization
    48 https://www.grid.ac/institutes/grid.4488.0 schema:Organization
    49 https://www.grid.ac/institutes/grid.4562.5 schema:Organization
    50 https://www.grid.ac/institutes/grid.5330.5 schema:Organization
    51 https://www.grid.ac/institutes/grid.6363.0 schema:Organization
    52 https://www.grid.ac/institutes/grid.7450.6 schema:Organization
    53 https://www.grid.ac/institutes/grid.7497.d schema:Organization
    54 https://www.grid.ac/institutes/grid.7727.5 schema:Organization
    55 https://www.grid.ac/institutes/grid.7839.5 schema:Organization
    56 https://www.grid.ac/institutes/grid.8379.5 schema:Organization
    57 https://www.grid.ac/institutes/grid.9018.0 schema:Organization
    58 https://www.grid.ac/institutes/grid.9647.c schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...